Caution should be used if patient is on a loop diuretic.Renal panel within 2-4 weeks pre-infusion and 10-14 days post ordered.On calcium/ Vitamin D 1200mg/800IU daily, in divided doses.The recommended dose is a 5 mg infusion for the treatment of Paget’s disease of bone.In patients with osteoporosis, the current recommended daily intake of calcium is 1200 mg in divided doses and vitamin D 800 IU to 1000 IU daily.Intravenous zoledronic acid is given for the prevention of osteoporosis as 5mg once every 2 years.Intravenous zoledronic acid for treatment of postmenopausal osteoporosis, treatment to increase bone mass in men with osteoporosis, and treatment and prevention of glucocorticoid-induced osteoporosis is 5mg per 100mL once every 12 months.Paget’s disease of bone in males and females - Treatment of Paget's disease of bone in men and women.Glucocorticoid induced osteoporosis - treatment and prevention of glucocorticoid-induced osteoporosis.Postmenopausal osteoporosis: Prevention of male Osteoporosis - treatment to increase bone mass in men with osteoporosis.Postmenopausal osteoporosis: Prevention of female Osteoporosis - treatment and prevention of postmenopausal osteoporosis.Bisphosphonates specifically act on bone cells (osteoclasts) to inhibit bone resorption and turnover activity and reduce progressive bone loss and risk for fracture.įinancial Assistance FDA-Approved Indications Bone is a living tissue constantly being remodeled. Unlike other common bisphosphonates that are taken by mouth, Reclast bypasses the stomach because it is an infusion into the bloodstream.

ZOLEDRONIC ACID (Reclast) Zoledronic acid is a bisphosphonate prescribed to prevent or treat osteoporosis or Paget's disease.

Blood bowl rules pdf